Mark Louis Friedman's most recent trade in Axogen Inc. was a trade of 35,829 Restricted Stock Units done . Disclosure was reported to the exchange on March 16, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Axogen Inc | Mark Louis Friedman | VP Regulatory Affairs & Policy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 35,829 | 35,829 | - | - | Restricted Stock Units | |
| Axogen Inc | Mark Louis Friedman | VP Regulatory Affairs & Policy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 33,419 | 33,419 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc | Mark Louis Friedman | VP Regulatory Affairs & Policy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 6,000 | 6,000 | - | - | Restricted Stock Units | |
| Axogen Inc | Mark Louis Friedman | VP Regulatory Affairs & Policy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 6,000 | 25,845 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc | Mark Louis Friedman | VP Regulatory Affairs & Policy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.97 per share. | 16 Mar 2022 | 1,502 | 24,343 (0%) | 0% | 8.0 | 11,971 | Common Stock |
| Axogen Inc | Mark Louis Friedman | VP Regulatory Affairs & Policy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,181 | 20,202 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc | Mark Louis Friedman | VP Regulatory Affairs & Policy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.42 per share. | 15 Feb 2022 | 357 | 19,845 (0%) | 0% | 8.4 | 3,006 | Common Stock |
| Axogen Inc | Mark Louis Friedman | VP Regulatory Affairs & Policy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2021 | 1,150 | 17,738 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc | Mark Louis Friedman | VP Regulatory Affairs & Policy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2021 | 1,150 | 1,150 | - | - | Restricted Stock Units | |
| Axogen Inc | Mark Louis Friedman | VP Regulatory Affairs & Policy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.74 per share. | 27 Dec 2021 | 286 | 17,452 (0%) | 0% | 9.7 | 2,786 | Common Stock |
| Axogen Inc | Mark Louis Friedman | VP Regulatory Affairs & Policy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 375 | - | - | - | Restricted Stock Units | |
| Axogen Inc | Mark Louis Friedman | VP Regulatory Affairs & Policy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 375 | 16,683 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc | Mark Louis Friedman | VP Regulatory Affairs & Policy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.24 per share. | 20 Dec 2021 | 95 | 16,588 (0%) | 0% | 9.2 | 878 | Common Stock |